Generic Valsartan Lawsuit Filed Over Kidney Cancer Diagnosis

According to allegations raised in a recently filed product liability lawsuit, a Louisiana man was diagnosed with kidney cancer following exposure to generic valsartan pills, which were distributed for years with carcinogens that were a byproduct of the manufacturing process for the blood pressure drug.

Raymond Rollins filed the complaint (PDF) last month in New Jersey federal court, indicating he received contaminated valsartan pills for years before the generic drug makers announced recalls.

The lawsuit names Zhejiang Huahai Pharmaceutical Co., Prinston Pharmaceutical, Inc., Solco Healthcare, Teva Pharmaceuticals and Actavis as defendants, indicating that they manufactured blood pressure drugs Rollins received between September 2013 and February 2017. Due to chemical impurities contained in the pills, Rollins indicates that he was diagnosed with kidney cancer in April 2018.

VALSARTAN LAWSUITS

Were you prescribed contaminated Valsartan drugs?

Side effects of recalled valsartan may increase the risk of cancer, due to an impurity discovered in certain generic versions of the hypertension drug.

Learn More About this Lawsuit SEE IF YOU QUALIFY FOR COMPENSATION

Although the drug makers knew or should have known about the potential risks associated with their pills, the lawsuit indicates that warnings were not provided to consumers or the medical community until several months after his cancer diagnosis, when the FDA began a string of generic valsartan recalls.

“As a result of Plaintiff’s ingestion of contaminated valsartan, Plaintiff developed and was diagnosed with cancer, which caused permanent and disabling injuries,” the lawsuit states. “Plaintiff would not have consented to taking valsartan, had Plaintiff known of or been fully and adequately informed by Defendants of the true increased risks and serious dangers of taking the drug, which was rendered unreasonably dangerous by the presence of NDMA and/or NDEA.”

The case joins a growing number of valsartan recall lawsuits filed in recent months by individuals who indicate they were left with liver cancer, kidney cancer, bladder cancer, gastric cancer and other injuries following exposure to the chemicals N-nitrosodimethylamine (NDMA) or N-Nitrosodiethylamine (NDEA) found in recalled valsartan pills.

In addition, a number of valsartan class action claims are pursuing damages for users of the medications who have not been diagnosed with cancer, but seek reimbursement for the cost of what were essentially worthless drugs, and funding for medical monitoring they may require for the rest of their lives due to their exposure to cancer-causing agents.

Image Credit: |

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

More Than 9,600 Join Suboxone Lawsuit Over Tooth Decay in MDL Filing
More Than 9,600 Join Suboxone Lawsuit Over Tooth Decay in MDL Filing (Posted today)

A bundled complaint of about 9,600 Suboxone lawsuits were filed in federal court on Friday, ahead of the two-year anniversary of the FDA requiring tooth decay label warnings on the opioid treatment film strips, which is also a deadline for filing a civil complaint in many states.

Lawyers Propose Direct Filing of Toxic Baby Food Lawsuits Over Autism, ADHD in Federal MDL
Lawyers Propose Direct Filing of Toxic Baby Food Lawsuits Over Autism, ADHD in Federal MDL (Posted today)

A federal judge has been asked to allow direct filing of future baby food lawsuits over autism and ADHD side effects with the MDL court, but the parties disagree over whether that order should allow multi-plaintiff complaints.

Social Media Mental Health Warnings Should Be Required To Protect Teens: U.S. Surgeon General
Social Media Mental Health Warnings Should Be Required To Protect Teens: U.S. Surgeon General (Posted 2 days ago)

U.S. Surgeon General says social media platforms like Facebook, Instagram and Tiktok should carry label warnings, alerting parents that youth who use the platforms face an increased risk of mental health side effects.